NDC Pharmacologic Class N0000190857 Janus Kinase Inhibitors [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0069-0501Xeljanz XRTofacitinibTablet, Film Coated, Extended ReleaseOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-1001Xeljanz TofacitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-1002Xeljanz TofacitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
63539-012Xeljanz TofacitinibTablet, Film CoatedOralU.s. PharmaceuticalsHuman Prescription Drug
63539-016Xeljanz TofacitinibTablet, Film CoatedOralU.s. PharmaceuticalsHuman Prescription Drug
63539-501Xeljanz XRTofacitinibTablet, Extended ReleaseOralU.s. PharmaceuticalsHuman Prescription Drug

There are 6 NDC products with the pharmacologic class Janus Kinase Inhibitors [MoA].